97029 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans; Receptors; Cell surface antigens; Cell surface determinants Immunoglobulin superfamily
Extracellular novel RAGE binding protein ( EN-RAGE) and uses thereof
#1202Aptameric IgE peptides in a protein scaffold as an allergy vaccine
#1203Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
#1204PELCAM-1-related molecules compositions kit of parts and associated methods of use
#1205Peptides with anti-proliferative activity
#1206Polynucleotides and Polypeptides Encoding Receptors
#1207Modified leukocyte Ig-like receptor family members (LIRs) with increased affinity for class 1 MHC and their uses in modulating T-cell activation
#1208Methods of Treating Diseases by Targeting Silt3
#1209Rage protein derivatives
#1210F11 RECEPTOR (F11R) ANTAGONISTS AS THERAPEUTIC AGENTS
#1211Imaging, diagnosis and treatment of disease
#1212Method for inhibiting tumor invasion or spreading in a subject
#1213Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof
#1214F11 receptor (F11R) antagonists as therapeutic agents
#1215Heteroclitic analogs and related methods
#1216Modified KSA and Uses Thereof
#1217Modulating robo: ligand interactions
#1218GLYCOPROTEIN VI FUSION PROTEINS
#1219Polynucleotides encoding molecules designated LDCAM
#1220Compositions and methods for treatment of neoplastic disease
#1221BTL-II nucleic acids
#1222Pancreatic cancer targets and uses thereof
#1223Methods, products and uses involving platelets and/or the vasculature
#1224Bioassays
#1225Compounds comprising lpa
#1226vWFA and/or ANTIG domain containing proteins
#1227sRAGE mimetibody, compositions, methods and uses
#1228Compositions and methods for treatment of cervical cancer
#1229Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#1230THERAPEUTIC AND DIAGNOSTIC CLONED MHC-UNRESTRICTED RECEPTOR SPECIFIC FOR THE MUC1 TUMOR ASSOCIATED ANTIGEN
#1231Inhibiting collagen-induced platelet aggregation and activation with peptide variants
#1232Fgfr binding peptides
#1233Immunogenic CD19 peptides
#1234Diagnosis of autoimmune disease
#1235Methods of treating cancer by administering antibodies to CD200
#1236Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
#1237Methods of Therapy and Diagnosis Using Immunotargeting of CD84Hy1-expressing Cells
#1238T cell receptors and related materials and methods of use
#1239Methods and Materials Relating to CD84-like Polypeptides and Polynucleotides
#1240Recombinant vector expressing multiple costimulatory molecules and uses thereof
#1241Methods and compositions concerning antibodies that bind CD84-like polypeptides
#1242Antibodies that bind LDCAM
#1243Humanized immunoglubulin reactive with alph4beta7 integrin
#1244Rage Fusion Proteins And Methods Of Use
#1245Carcinoembryonic antigen fusions and uses thereof
#1246ITL3 polypeptides and uses thereof
#1247TREATMENT OF CHEMOTHERAPY- OR RADIOTHERAPY-RESISTANT TUMORS
#1248DAP12 nucleic acids
#1249Method of enhancing a targeted immune response against tumors
#1250Confluence regulated adhesion molecules useful in modulating vascular permeability
#1251Soluble Bifunctional Proteins
#1252Imaging, diagnosis and treatment of disease
#1253MODULATION OF CD200 RECEPTORS
#1254Methods and Materials Relating to CD84-like Polypeptides and Polynucleotides
#1255Preventives/Remedies for Cancer
#1256Methods for Reducing Seizure-Induced Neuronal Damage
#1257Methods for chemically synthesizing immunoglobulin chimeric proteins
#1258Method of modulating cell survival, differentiation and/or synaptic plasticity
#1259Inflammation treatment, detection and monitoring via TREM-1
#1260Heparin Binding Peptide
#1261Imaging, diagnosis and treatment of disease
#1262Glycoprotein VI fusion proteins
#1263NOVEL GLYCOSYLATED PEPTIDE TARGET IN NEOPLASTIC CELLS
#1264DENDRITIC CELL POTENTIATION
#1265Genetically engineered and phenotyped mice and stem cell clones for producing the same
#1266MAMMALIAN CELL MEMBRANE PROTEINS; RELATED REAGENTS
#1267THERAPEUTIC AND DIAGNOSTIC AGENTS
#1268Imaging, diagnosis and treatment of disease
#1269Antibodies to MAdCAM
#1270Modified CEA/B7 vector
#1271CEACAM1 mediated protective immunity
#1272Bi-functional peptides for multiple sclerosis treatment and diagnosis
#1273NK cell activation inducing ligand (NAIL) DNA and polypeptides, and use thereof
#1274Polynucleotides and Polypeptides Encoding Receptors
#1275Nonhuman model animal of Th2-mediated hyperimmune response
#1276RAGE fusion proteins, formulations, and methods of use thereof
#1277ILT3 binding molecules and uses therefor
#1278Use of Agents Derived from Ceacam1 for the Treatment of Inflammatory Diseases
#1279Vaccine Composition Comprising a Class II Cmh Lignd Coupled With an Antigen, Method for the Preparation and the Use Thereof
#1280Inhibitors of L1 and ADAM10 for the treatment of carcinomas
#1281Immunogenic proteoliposomes, and uses thereof
#1282Compositions and Methods for Inducing Anti-Tumor Immunity
#1283Methods and Compositions for Antagonism of RAGE
#1284COMPOSITIONS AND METHODS FOR MODULATING IMMUNE RESPONSES
#1285Methods of treating cancer by administering antibodies to CD200
#1286Methods for Preventing and Treating Amyloidogenic Diseases
#1287Dendrite cells transduced with recombinant adenovirus AdVCEA which generate CEA-specific cytotoxic T lymphocytes, vaccine and pharmaceutical composition comprising the same
#1288BINDING POLYPEPTIDES WITH RESTRICTED DIVERSITY SEQUENCES
#1289Methods, arrangements and systems for obtaining information associated with an anatomical sample using optical microscopy
#1290Soluble CD83 proteins and use thereof for the treatment and prevention of a disease or medical condition caused by dysfunction or undesired function of a cellular immune response involving T cells
#1291Fragments of NKp44 and NKp46 for targeting viral-infected and tumor cells
#1292Methods of upmodulating an immune response with non-activating forms of B7-4
#1293Methods and compositions for modulating immunity
#1294Methods and compositions relating to restricted expression lentiviral vectors and their applications
#1295Mutated anti-cd22 antibodies and immunoconjugates
#1296Modulation of MDL-1 activity for treatment of inflammatory disease
#1297Mucosal vascular addressins and uses thereof
#1298Immunoglobulin chimeric monomer-dimer hybrids
#1299Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
#1300RECOMBINANT PLATELET COLLAGEN RECEPTOR GLYCOPROTEIN VI AND ITS PHARMACEUTICAL USE
#1301Use of soluble forms of CD83 and nucleic acids encoding them for the treatment or prevention of diseases
#1302Antibodies to MAdCAM
#1303Methods and materials relating to novel polypeptides and polynucleotides
#1304Renal Regulatory Elements and Methods of Use Thereof
#1305Novel polynucleotide and polypeptide sequences and uses thereof
#1306Diagnosis and treatment of hepatic disorders
#1307Molecules with extended half-lives, compositions and uses thereof
#1308Nectin polypeptides, polynucleotides, methods of making and use thereof
#1309Methods and compositions for inhibition of immune responses
#1310Method to screen phage display libraries with different ligands
#1311Pharmaceutical composition for treatment of immunological disorders
#1312Modulation of immunity and CEACAM1 activity
#1313Synthetic gene encoding human carcinoembryonic antigen and uses thereof
#1314Isoforms of receptor for advanced glycation end products (RAGE) and methods of identifying and using same
#1315Use of chimeric receptors in a screening assay for identifying agonists and antagonists of cell receptors
#1316CEACAM1 based cancer therapy and diagnosis
#1317Agents which bind to epitopes of glycoprotein VI
#1318Novel human cell surface protein with immunoglobulin folds, BGS-19
#1319Polynucleotides encoding novel isoforms of IGSF9
#1320PRAME peptide analogues
#1321Melanoma antigen peptide analogues
#1322Diagnosis and treatment of hepatic disorders
#1323PSMA peptide analogues
#1324Carcinoembryonic antigen (CEA) peptides
#1325ILT3 binding molecules and uses therefor
#1326Imaging, diagnosis and treatment of disease
#1327gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
#1328HUMAN CCV POLYPEPTIDES
#1329Structure for presenting desired peptide sequences
#1330Humanized immunoglobulin reactive with α4β7 integrin
#1331Methods for stabilizing proteins
#1332Cell surface receptor isoforms and methods of identifying and using the same
#1333Therapeutic and diagnostic agents
#1334Method for producing a mammal provided with resistance to an alpha-herpes virus mediated infection and mamal obtained by implementing said method and said mamal's progeny
#1335Co-stimulatory polypeptides
#1336Compositions and methods for treatment of non-hodgkins lymphoma
#1337Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen
#1338Chimeric cytoplasmic signalling molecules
#1339T cell regulation
#1340Inhibition of T cell activation by butyrophilin 4 or B7-L1
#1341Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof
#1342KIM-1 antagonists and use to modulate immune system
#1343Methods for detecting vasculopathies and tumors
#1344BIVM (basic, immunoglobulin-like variable motif-containing) gene, transcriptional products, and uses thereof
#1345Molecules with extended half-lives, compositions and uses thereof
#1346Diagnostic and prognostic compounds and method
#1347Methods and compositions for manipulating the guided navigation of endothelial tubes during angiogenesis
#1348B7-4 Antibodies and uses therefor
#1349Chimeric protein
#1350Compositions and methods for treating rage-associated disorders
#1351Compounds and molecular complexes comprising multiple binding regions directed to transcytotic ligands
#1352PECAM-1-related molecules compositions kit of parts and associated methods of use
#1353DNA encoding a mast cell-derived membrane protein
#1354Methods of therapy and diagnosis using immunotargeting of CD84Hy1-expressing cells
#135512 human secreted proteins
#1356Hla-a1,-a2,-a3,-a24,-b7, and-b44 tumor associated antigen peptides and compositions
#1357Compositions and methods of purifying myelin-associated glycoprotein (MAG)
#1358sRAGE mimetibody, compositions, methods and uses
#1359Manipulation of cytokine levels using CD83 gene products
#1360Hla binding peptides and their uses
#1361Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR)
#1362Peptides capable of inducing attraction to the axonal growth and their use for treating neurodegenerative diseases
#1363RAGE protein derivatives
#1364Mucosal vascular addressins and uses thereof
#1365Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides
#1366Nucleic acid encoding DS-CAM proteins and products related thereto
#1367Methods and compositions for modulating tumor growth
#1368Therapeutic use of anti-CS1 antibodies
#1369Method for the detection of carcinoembryonic agent and cancer diagnosis method based thereon
#1370Heteroclitic analogs and related methods
#1371Transgenic animals expressing transglutaminase II
#1372Purified and isolated protein zero related (PZR) and therapeutic and screening methods using same
#1373Nucleotide sequence encoding PTD and CEA fusion protein, TAT-CEA fusion protein, anti-tumor vaccine and pharmaceutical composition for treating tumor comprising the fusion protein
#1374Antibodies that specifically bind to FDF03
#1375DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
#1376Confluence regulated adhesion molecules useful in modulating vascular permeability
#1377Novel nucleic acids and polypeptides
#1378F11 receptor (F11R) antagonists as therapeutic agents
#1379Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
#1380Novel receptor trem (triggering receptor expressed on myeloid cells) and uses thereof
#1381Receptor for Oncostatin M
#1382Dendritic cell potentiation
#1383Transgenic aves producing human polyclonal antibodies
#1384Human antibodies that bind human MAdCAM
#1385Transgenesis by sperm-mediated gene transfer
#1386Triggering receptor involved in natural cytotoxicity mediated by human natural killer cells and antibodies that identify the same
#1387Treatment of complement-associated disorders
#1388Novel human phosphatases and polynucleotides encoding the same
#1389Method to screen phage display libraries with different ligands
#1390Modulating Robo: ligand interactions
#1391CTLA4-Cy4 fusion proteins
#1392Tim-3 ligands and methods thereof
#1393Method of enhancing a targeted immune response against tumors
#1394TREM-1 splice variant for use in modifying immune responses
#1395Polynucleotides and polypeptides encoding receptors
#1396Method of stabilizing protein
#1397Extracellular junctional adhesion molecules
#1398Novel co-stimulatory molecules
#1399NCAM binding compounds
#1400CEA/NCA-based differentiation cancer therapy
#1401Methods and materials relating to novel growth regulatory-like polypeptides and polynucleotides
#1402Antigen presenting system and methods for activation of T-cells
#1403Immunoadhesin comprising a glycoprotein VI domain
#1404Polypeptides associated with activatory receptors and their biological applications
#1405Secreted and transmembrane polypeptides and nucleic acids encoding the same
#1406Human proteins
#1407Compositions and methods for the treatment and diagnosis of immune disorders
#1408Compositions and methods for treatment of neoplastic disease
#1409Porcine invariant chain protein, full length cDNA, genomic organization, and regulatory region
#1410CD200 receptors
#1411T cell regulatory genes associated with immune disease
#1412Nonhuman model animal of Th2-mediated hyperimmune response
#1413Novel tumor-associated antigens
#1414Antibodies and fragments thereof to MDL-1 protein
#1415Generation of stabilized proteins by combinatorial consensus mutagenesis
#1416Polynucleotides encoding immunoadhesins comprising a glycoprotein VI domain
#1417Survical promoting ncam binding and ncam ligand binding compounds
#1418Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule
#1419Immunogenic CEA
#1420Isolated mammalian monocyte cell genes; related reagents
#1421Complex formation for the stabilisation and purification of proteins of interest
#1422Compositions and methods to prevent metastasis from primary malignancies
#1423Polynucleotides encoding a novel human neuronal cell adhesion protein, BGS-28, and variants thereof
#1424Immunogenic peptides
#1425Methods of treating allergy by administering a CD200 protein
#1426Structure for presenting desired peptide sequences
#1427Immunoglobulin chimeric monomer-dimer hybrids
#1428Novel molecules of the FTHMA-070-related protein family and the T85-related protein family and uses thereof
#1429Methods and materials relating to CD84-like polypeptides and polynucleotides
#1430Methods for chemically synthesizing immunoglobulin chimeric proteins
#1431Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#1432Genetically-modified cells comprising a modified human T cell receptor alpha constant region gene
#1433Nucleic acid of recombination expression vector encoding soluble forms of CD83, host cells transformed/transfected therewith and pharmaceutical compositions containing same